0001493152-20-014583.txt : 20200804 0001493152-20-014583.hdr.sgml : 20200804 20200804142558 ACCESSION NUMBER: 0001493152-20-014583 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Purcell Richard David Jr. CENTRAL INDEX KEY: 0001639306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16467 FILM NUMBER: 201072725 MAIL ADDRESS: STREET 1: 65 FAIR HAVEN ROAD CITY: FAIR HAVEN STATE: NJ ZIP: 07704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RespireRx Pharmaceuticals Inc. CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 BUSINESS PHONE: (201) 444-4947 MAIL ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 FORMER COMPANY: FORMER CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2020-07-31 0 0000849636 RespireRx Pharmaceuticals Inc. RSPI 0001639306 Purcell Richard David Jr. C/O RESPIRERX PHARMACEUTICALS INC. 126 VALLEY ROAD, SUITE C GLEN ROCK NJ 07452 0 1 0 0 SVP - Research and Development Common Stock Options (to purchase shares of Common Stock) 0.0072 2020-07-31 4 A 0 5000000 0.00 A 2025-07-31 Common Stock 5000000 5000000 D These Common Stock Options vest in four equal installments: 25 percent on July 31, 2020 (the grant date), 25 percent on September 30, 2020, 25 percent on December 31, 2020, and 25 percent on March 31, 2021. /s/ Richard D. Purcell, Jr. 2020-08-04